Results 11 to 20 of about 8,059 (213)

Toxic megacolon: A rare presentation and novel treatment. [PDF]

open access: yesJPGN Rep
Abstract A 14‐year‐old male presented with toxic megacolon (TM). Stool culture and rectal biopsies ruled out Clostridium difficile infection and Hirschsprung disease, respectively. Anorectal manometry ruled out anal achalasia as rectoanal inhibitory reflex elicited a normal resting pressure.
Davis AP, Schuh JM, Bitong J, Wagner AJ.
europepmc   +2 more sources

Toxic megacolon complicating a first course of Crohn’s disease: about two cases

open access: yesClinics and Practice, 2013
Toxic megacolon is a rare and serious complication of Crohn’s disease. Because of the associated high morbidity and mortality, early recognition and management of toxic megacolon is important.
Rania Hefaiedh   +4 more
doaj   +1 more source

Health outcomes of statin users compared to non-users with Clostridium difficile infection [PDF]

open access: yes, 2017
Background: Clostridium difficile infection (CDI) is the most common cause of nosocomial diarrhea, and the primary cause of healthcare-associated infections in the United States. Statins have beneficial effects independent of their lipid-lowering effects;
Argamany, Jacqueline Rose
core   +1 more source

Toxic Megacolon

open access: yesMedizinische Klinik, Intensivmedizin und Notfallmedizin, 2017
Toxic megacolon constitutes a feared, life-threatening complication of severe intestinal inflammation and is a challenge for interdisciplinary medical care.Specific aspects of conservative treatment based on current scientific evidence derived from guidelines, qualified reviews, and scientific studies are presented, which provide a rational approach ...
M, Leppkes   +3 more
  +6 more sources

Shigellosis and toxic megacolon secondary to Shigella flexneri serotype 3a: The challenges of laboratory diagnosis

open access: yesInternational Journal of Infectious Diseases, 2018
We present a rare case of Shigella flexneri bacteraemia and toxic megacolon, and discuss the challenges of conventional laboratory techniques versus molecular PCR platforms in differentiating between Shigella species and Escherichia coli.
Emma McGuire   +3 more
doaj   +1 more source

Clostridium difficile ribotypes in Austria: a multicenter, hospital-based survey [PDF]

open access: yes, 2015
A prospective, noninterventional survey was conducted among Clostridium difficile positive patients identified in the time period of July until October 2012 in 18 hospitals distributed across all nine Austrian provinces.
A Goorhuis   +38 more
core   +1 more source

Fatal Toxic Megacolon in a Child of Hirschsprung Disease [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2016
Hirschsprung disease (HD) in late childhood is uncommon and often undiagnosed or misdiagnosed. However, in a patient with Hirschsprung disease, of greater significance is the occurrence of life threatening enterocolitis. In its more severe form, this is
Shiwani R Garg   +3 more
doaj   +1 more source

Controlling clostridium difficile [PDF]

open access: yes, 2013
Clostridium difficile infection causes colitis and is closely associated with the use of antimicrobials, probably due to disruption of the normal bowel flora.
Hajkowicz, Krispin, McFarlane, Mark
core   +1 more source

Pseudomembranous colitis complicated by toxic megacolon in oncological patients

open access: yesActa Biomedica Scientifica, 2023
In recent years, information on the increase in the incidence of  infection associated with Clostridioides difficile (CDI) has appeared in the literature. It is known that C.
D. D. Morikov   +3 more
doaj   +1 more source

Clinical course of severe colitis: a comparison between Crohn’s Disease and ulcerative colitis [PDF]

open access: yes, 2013
Pochi sono i dati disponibili sul decorso clinico della malattia di Crohn del colon severa(CD). L'obiettivo è quello di descrivere il decorso clinico della colite di Crohn severa (CC) in una coorte di pazienti isolata con CD del colon o ileocolica, e di ...
Modesto, Irene <1978>
core   +1 more source

Home - About - Disclaimer - Privacy